See also this year's filing and all EDGAR filings for this company.
PDF Report 0001600132_2020_Bellerophon_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001600132, Bellerophon Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,382,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 316,000 |
| 3 | remainder_Assets | 2,410,000 |
| 4 | LiabilitiesCurrent | 7,584,000 |
| 5 | LiabilitiesNoncurrent | 1,659,000 |
| 6 | remainder_Liabilities | 274,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,528,759 |
| 9 | ResearchAndDevelopmentExpense | 13,055,490 |
| 10 | remainder_Expenses | -3,955,634 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 371,074 |
| 13 | remainder_ComprehensiveNetIncome | -1,869 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,108,000 |
| 1 | Liabilities | 9,517,000 |
| 2 | Expenses | 15,628,615 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 3,591,000 |
| 5 | NetIncome | -15,257,541 |
| 6 | ComprehensiveNetIncome | -15,258,476 |
| 7 | BaseVar | 19,313,279 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.657 |
| 9 | EconomicCapitalRatio | 1.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
